ARCHIVES

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

This article is from The Cancer Letter archive.

Vol. 35 No. 29 | July 24, 2009

Download PDF Visit The Full Archive

Related Articles

In Breif: Baltimore Developer Donates $10 Million To Univ. of Maryland Medical System

July 19, 1996

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

Medicare Should Pay Routine Care For Patients in Trials: IOM.

January 7, 2000

NCI: The Times Have Been “Confusing,” Acting NCI Director Niederhuber Admits in Memo.

June 9, 2006

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013